Edition:
United Kingdom

Aclaris Therapeutics Inc (ACRS.OQ)

ACRS.OQ on NASDAQ Stock Exchange Global Select Market

19.85USD
18 Jun 2018
Change (% chg)

$-0.08 (-0.40%)
Prev Close
$19.93
Open
$19.91
Day's High
$20.02
Day's Low
$19.57
Volume
50,937
Avg. Vol
101,184
52-wk High
$30.06
52-wk Low
$16.24

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 1.12 -0.979
FY 2017 Dec '17 1.00 -0.802
Sep '17 0.68 -0.631
Jun '17 0.00 -0.558
Mar '17 0.00 -0.482
FY 2016 Dec '16 0.00 -0.491
Sep '16 0.00 -0.499
Jun '16 0.00 -0.623
Mar '16 0.00 -0.646
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 5 2.07 3.04 1.00 --
Quarter Ending Sep-18 5 4.54 5.50 3.76 --
Year Ending Dec-18 5 16.69 18.53 14.30 31.41
Year Ending Dec-19 6 70.59 94.13 54.30 136.92
Earnings (per share)
Quarter Ending Jun-18 3 -1.09 -0.94 -1.25 --
Quarter Ending Sep-18 3 -1.15 -1.05 -1.23 --
Year Ending Dec-18 4 -4.15 -3.39 -4.68 -3.05
Year Ending Dec-19 6 -3.25 -2.14 -4.10 -0.56
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 84.11 32.75
P/E High - Last 5 Yrs. -- 293.49 45.73
P/E Low - Last 5 Yrs. -- 91.70 24.23
Beta -- 0.90 0.88
Price to Sales (TTM) -- 111.03 5.71
Price to Book (MRQ) 4.39 13.59 5.37
Price to Tangible Book (MRQ) 4.93 14.06 6.94
Price to Cash Flow (TTM) -- 71.48 23.33
% Owned Institutions 86.59 12.72 2.16

Dividends

  Company industry sector
Dividend Yield -- 0.30 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.51
Dividend 5 Year Growth Rate -- 1.66 5.32
Payout Ratio(TTM) -- 15.73 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 399.57 7.90
Sales (TTM) vs TTM 1 Yr. Ago -- 78.92 5.69
Sales - 5 Yr. Growth Rate -- 32.16 10.32
EPS (MRQ) vs Qtr. 1 Yr. Ago 10.43 25.13 19.38
EPS (TTM) vs TTM 1 Yr. Ago 2.93 -- --
EPS - 5 Yr. Growth Rate -- 39.04 10.77
Capital Spending - 5 Yr. Growth Rate -- 40.32 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.81 2.19
Current Ratio (MRQ) 21.00 5.30 2.98
LT Debt to Equity (MRQ) 0.00 22.94 12.17
Total Debt to Equity (MRQ) 0.00 24.60 16.44
Interest Coverage (TTM) -- -99.47 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.04 54.45
Gross Margin - 5 Yr. Avg. -- 51.19 52.21
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -575.11 10.97
Operating Margin (TTM) -- -719.50 4.73
Operating Margin - 5 Yr. Avg. -- -596.43 6.40
Pre-Tax Margin (TTM) -- -693.95 5.57
Pre-Tax Margin - 5 Yr. Avg. -- -599.75 6.82
Net Profit Margin (TTM) -- -695.17 1.87
Net Profit Margin - 5 Yr. Avg. -- -602.62 3.09
Effective Tax Rate (TTM) -- 22.63 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.23 23.95

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 22,647,969 847,045,629
Net Income/Employee (TTM) -1,598,903 2,975,306 99,641,512
Receivable Turnover (TTM) -- 20.17 5.78
Inventory Turnover (TTM) -- 2.36 3.35
Asset Turnover (TTM) 0.00 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -36.33 -1.10 10.95
Return on Assets - 5 Yr. Avg. -- -0.58 12.32
Return on Investment (TTM) -38.27 1.56 14.38
Return on Investment - 5 Yr. Avg. -- 2.22 16.11
Return on Equity (TTM) -38.37 2.43 16.07
Return on Equity - 5 Yr. Avg. -- 3.12 17.39
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -95.66 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aclaris Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 0.58 -2.89 99 55
13 Week -1.71 -6.50 99 66
26 Week -14.92 -21.38 99 77
52 Week 12.14 -4.95 99 50
YTD 1.73 -10.66 99 59
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 145
Total Shares Held: 31,429,054
3 Mo. Net Change: 2,568,935
# New Positions: 14
# Closed Positions: 22
# Increased Positions: 76
# Reduced Positions: 56
# Net Buyers: 20
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.